Add BrightSurf on Google Email

Genetic variation enhances cancer drug sensitivity

A recent study from Uppsala University found that genetic variation in cancer cells can enhance the effects of an already approved cancer drug, talazoparib, against liver cancer cells lacking a functional CYP2D6 enzyme. This suggests a potential for more individually tailored and effective cancer therapies.

SourceUppsala University·JournalEBioMedicine·TypeExperimental study·DateNov 14, 2024

McMaster University researchers uncover potential treatment for rare genetic disorders

Researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases, two rare lysosomal storage disorders that cause progressive damage to nerve cells. The FDA-approved drug 4-phenylbutyric acid (4-PBA) showed significant improvements in motor function, lifespan, and healthy motor neurons.

SourceMcMaster University·JournalHuman Molecular Genetics·TypeExperimental study·DateNov 13, 2024

A 36-gene predictive score of anti-cancer drug resistance anticipates cancer therapy outcomes

Researchers developed a 36-gene predictive score that surpasses conventional methods in predicting tamoxifen treatment resistance. The polygenic score UAB36 has potential as a tool for personalized medicine, helping identify patients at higher risk of poor survival and suggesting alternative treatment strategies.

SourceUniversity of Alabama at Birmingham·Journalnpj Precision Oncology·TypeMeta-analysis·DateNov 7, 2024

New anti-cancer agent works without oxygen

A new anti-cancer agent has been developed that targets glutathione in cancer cells, switching it off and causing tumor shrinkage. The catalyst-based therapy accumulates specifically in tumor tissue, showing promising results in animal studies and potential for further human trials.

SourceRuhr-University Bochum·JournalNature Communications·TypeExperimental study·DateOct 31, 2024

High-tech tracking technology streamlines drug discovery

Researchers have developed a large-scale drug screening technique that tracks drug targets inside cells, allowing for the identification of potential new drugs. The technology screens candidate drugs 100 times faster than standard manual techniques, enabling the discovery of previously unknown drugs.

SourceOsaka University·JournalNature Communications·DateOct 31, 2024

Researchers at Tel Aviv University discovered a cancer mechanism that can eliminate tumors – even those resistant to immunotherapy

Researchers at Tel Aviv University have discovered a new cancer mechanism that prevents the immune system from attacking tumors. The discovery was made by reversing this mechanism, which stimulates the immune system to fight cancer cells, including those resistant to prevailing forms of immunotherapy.

SourceTel-Aviv University·JournalNature Communications·DateOct 30, 2024

Phase Two results with CRISPR-Cas9 gene editing support further development as treatment for hereditary angioedema (HAE)

A CRISPR-Cas9 based gene editing therapy has been shown to reduce angioedema attacks and sustainably lower kallikrein levels in patients with hereditary angioedema, offering a potential treatment option. The therapy was tested on 27 patients across two dosages compared to placebo.

SourceAmsterdam University Medical Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 24, 2024

How blood cancer cells rewire to evade drug treatment

Researchers found that blood cancer cells rewired their gene regulatory networks to evade drug treatment in Acute Myeloid Leukemia (AML), disrupting normal differentiation and growth. The study identified key findings, including changes in open chromatin regions and the loss of binding of RUNX1 and AP-1 transcription factors.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateOct 23, 2024

Cognitive-behavioral therapy for medical non-adherence: A topical review and clinical recommendations

Cognitive-behavioral therapy (CBT) is a promising intervention for addressing medical non-adherence in pediatric patients with chronic illnesses. CBT successfully integrates principles of learning theory and cognitive science to address behavioral and emotional challenges that affect health outcomes.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateOct 21, 2024

Smaller vial size for Alzheimer’s drug could save Medicare hundreds of millions per year

A new study suggests that introducing a smaller vial size for the Alzheimer's drug lecanemab could reduce waste by 74% and save Medicare up to $336 million per year. This is due to the high amount of unused medication being discarded, with each patient often receiving a dose lower than the available vial sizes.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateOct 14, 2024

A new technique that makes competition between tumour cells visible can help personalise treatments for multiple myeloma

A new technique called Clonal competition assays helps understand the evolutionary advantages of multiple myeloma cells over available treatments. It allows researchers to see how each population of cells in the same myeloma reacts to treatments, getting closer to understanding heterogeneity and resistance.

Online insomnia treatment can help caregivers get much-needed rest, study suggests

A study suggests that online insomnia treatment, SHUTi, can provide meaningful relief for caregivers struggling with sleep difficulties. The program showed promising results in improving sleep quality and reducing stress among high-intensity caregivers, those shouldering the greatest responsibilities in caring for their loved ones.

SourceUniversity of Virginia Health System·JournalAnnals of Behavioral Medicine·DateOct 2, 2024